Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 4Recruiting 2Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Interventions

ixabepilone 1ST 1481 1Paclitaxel 1Fulvestrant 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Completed × Solid Malignancies × Clear all
NCT00162136 2020-11-02

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

R-Pharm

Phase 1 Completed
35 enrolled 17 charts

Solid Malignancies

NCT01540526 2019-11-19

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

University of Wisconsin, Madison

Phase 1 Completed
24 enrolled
Genitourinary

Solid Malignancies

NCT02640755 2019-04-22

14C

AstraZeneca

Phase 1 Completed
4 enrolled 34 charts

Solid Malignancies

NCT00033202 2009-06-03

This is an Early Study to Investigate the Effect of GimatecanĀ® in Adults With Solid Tumor

Sigma-Tau Research, Inc.

Phase 1 Completed
30 enrolled

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚔